Myelomatosis
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL (NCT05153330) | Biomea Fusion Inc. | 2022-01-24 |
| Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma (NCT04782687) | US Oncology Research | 2021-09-10 |
| MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma (NCT02057640) | Jason Valent | 2014-05-22 |
| Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma (NCT01239368) | National Cancer Institute (NCI) | 2010-11-10 |
Track Myelomatosis automatically
Every clearance here is in the API, with alerts when new ones post.